KRYS icon

Krystal Biotech
KRYS

Overview Fund Activity

137 hedge funds and large institutions have $1.36B invested in Krystal Biotech in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 46 increasing their positions, 52 reducing their positions, and 15 closing their positions.

Holders
137
Holders Change
+2
Holders Change %
+1.48%
% of All Funds
2.32%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
19
Increased
46
Reduced
52
Closed
15
Calls
$9.2M
Puts
$3.87M
Net Calls
+$5.32M
Net Calls Change
+$2.9M

Top Buyers

1
FLSM
1
Frazier Life Sciences Management
California
$71.9M
2
RCMNY
2
Rubric Capital Management (New York)
New York
$6.08M
3
Skandinaviska Enskilda Banken (SEB)
3
Skandinaviska Enskilda Banken (SEB)
Sweden
$19.5M
4
RG
4
Redmile Group
California
$125M
5
ACA
5
Avoro Capital Advisors
New York
$70.6M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$103M
2
FLAM
2
First Light Asset Management
Minnesota
$39.1M
3
SCM
3
Soleus Capital Management
Connecticut
$14.1M
4
Jennison Associates
4
Jennison Associates
New York
$0
5
Lord, Abbett & Co
5
Lord, Abbett & Co
New Jersey
$73.4M
Name Market Value Shares Shares
Change 		Shares
Change %
Group One Trading
151
Group One Trading
Illinois
– – – –
CFGS
152
Concourse Financial Group Securities
Alabama
– – – –
QCG
153
Quadrant Capital Group
Ohio
$0 4 – –
Nomura Asset Management
154
Nomura Asset Management
Japan
– – – –
AF
155
Allworth Financial
California
$0 2 +2 New
3 4 5 6
7